WDAY SRE ZU DPZ PCAR EBAY ADSK MYL LLTC DBD SWKS BKD DAL KAR DNKN SALE CRL ENDP CFX FIS FMC VMC DD CRM BMRN ROC ROC YELP AGN LVS LVS UTX BDX APD BXP BXP AMGN RGLD EXH CXO PKG BHI CNO COMM GPN RAI MWV BRE SWY
ARIAD Pharmaceuticals, Inc. (ARIAD) is biopharmaceutical company. As of December 31, 2011, the Companyï¿½s pipeline contains three product candidates: ponatinib, AP26113 and ridaforolimus. It is building a pipeline of product candidates that expand upon treatment options for patients with cancer. Each of its product candidates were discovered internally. It is building a commercial organization to market, distribute and sell its products upon regulatory approval in the United States, Europe and other select markets, worldwide. It has commenced preparations for the commercial launch of ponatinib in the United States and Europe.